The startup’s smartphone-administered digital therapeutic for fibromyalgia received FDA Breakthrough Device designation last year.
Swing Therapeutics scores $10.3M to support fibromyalgia DTx clinical trial
The startup’s smartphone-administered digital therapeutic for fibromyalgia received FDA Breakthrough Device designation last year.
